Revealing the intricacies of cancer.
Verhagen
Anne M
AM
The Walter and Eliza Hall Institute of Medical Research, Post Office Royal Melbourne Hospital, Victoria 3050, Australia. verhagen@wehi.edu.au
Lock
Peter
P
D017209:Apoptosis / Q000235:genetics / Q000502:physiology; D014408:Biomarkers, Tumor / Q000096:biosynthesis; D019496:Cancer Vaccines; D002453:Cell Cycle / Q000235:genetics / Q000502:physiology; D004260:DNA Repair / Q000235:genetics / Q000502:physiology; D004195:Disease Models, Animal; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D015972:Gene Expression Regulation, Neoplastic / Q000235:genetics / Q000502:physiology; D016147:Genes, Tumor Suppressor / Q000502:physiology; D020022:Genetic Predisposition to Disease; D008666:Metalloendopeptidases / Q000037:antagonists & inhibitors; D015166:Monitoring, Immunologic; D009369:Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics / Q000517:prevention & control; D009857:Oncogenes; D016160:Retinoblastoma Protein / Q000235:genetics / Q000502:physiology; D015398:Signal Transduction / Q000235:genetics / Q000502:physiology; D016159:Tumor Suppressor Protein p53 / Q000235:genetics / Q000502:physiology
D014408:Biomarkers, Tumor; D019496:Cancer Vaccines; D004791:Enzyme Inhibitors; D016160:Retinoblastoma Protein; D016159:Tumor Suppressor Protein p53; D008666:Metalloendopeptidases